Palisade Capital Management’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.8M | Sell |
919,459
-27,626
| -3% | -$595K | 0.56% | 70 |
|
|
2025
Q1 | $21.6M | Buy |
947,085
+113,937
| +14% | +$2.6M | 0.62% | 61 |
|
|
2024
Q4 | $21.6M | Buy |
833,148
+12,004
| +1% | +$312K | 0.58% | 68 |
|
|
2024
Q3 | $20.6M | Sell |
821,144
-411,568
| -33% | -$10.3M | 0.55% | 73 |
|
|
2024
Q2 | $26.4M | Sell |
1,232,712
-19,790
| -2% | -$424K | 0.72% | 49 |
|
|
2024
Q1 | $23.2M | Buy |
1,252,502
+39,168
| +3% | +$727K | 0.61% | 61 |
|
|
2023
Q4 | $19.7M | Sell |
1,213,334
-150,304
| -11% | -$2.44M | 0.52% | 69 |
|
|
2023
Q3 | $18.8M | Buy |
1,363,638
+229,286
| +20% | +$3.17M | 0.53% | 70 |
|
|
2023
Q2 | $25.1M | Buy |
1,134,352
+54,538
| +5% | +$1.21M | 0.67% | 52 |
|
|
2023
Q1 | $23.5M | Buy |
1,079,814
+50,191
| +5% | +$1.09M | 0.63% | 50 |
|
|
2022
Q4 | $18.7M | Buy |
1,029,623
+107,080
| +12% | +$1.95M | 0.5% | 68 |
|
|
2022
Q3 | $21M | Buy |
922,543
+2,359
| +0.3% | +$53.7K | 0.59% | 55 |
|
|
2022
Q2 | $12.7M | Buy |
920,184
+368,415
| +67% | +$5.09M | 0.34% | 90 |
|
|
2022
Q1 | $12.5M | Sell |
551,769
-38,219
| -6% | -$869K | 0.29% | 110 |
|
|
2021
Q4 | $22M | Buy |
589,988
+5,687
| +1% | +$212K | 0.45% | 77 |
|
|
2021
Q3 | $24.7M | Buy |
584,301
+108,617
| +23% | +$4.6M | 0.54% | 64 |
|
|
2021
Q2 | $21.2M | Buy |
475,684
+96,573
| +25% | +$4.3M | 0.48% | 73 |
|
|
2021
Q1 | $13.6M | Buy |
+379,111
| New | +$13.6M | 0.32% | 110 |
|